- Book
- April 2021
- 464 Pages
- Book
- October 2020
- 288 Pages
- Book
- March 2020
- 400 Pages
- Book
- February 2020
- 448 Pages
- Book
- April 2018
- 432 Pages
- Book
- December 2013
- 720 Pages
- Book
- April 2013
- 256 Pages
- Book
- June 2012
- 252 Pages
United States
- Book
- December 2010
- 368 Pages
- Book
- August 2023
Global

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more